drugset / Trial / NCT06171282
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Bone and Soft Tissue Tumors
Phase 0
Unknown
9 enrolled
Shanghai Yunying Medical Technology
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · collab
NaSingle-groupOpen-labelTreatment
Summary
9 participants are expected to be enrolled for this open，Single-armed clinical trial to evaluate the safety and efficacy of the recombinant herpes simplex virus Ⅰ, R130 in patients with advanced bone and soft tissue tumors.
Timeline
- Start
- 2023-07-12
- Primary completion
- 2025-07-12
- Completion
- 2026-07-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | R130 | Unknown | 1 ml | Other |
| Subject | R130 | Unknown | 2 ml | Other |